Trial of Rifaximin in Probable Alzheimer's Disease

Clinical trial NCT03856359 · COMPLETED

Trial details

NCT number: NCT03856359
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2019-04-09
Primary completion: 2020-11-19
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.